Furthermore, while systemic increases in IL-1β, IL-6, TNF-α, and IFN-γ have traditionally been viewed as immunopathological hallmarks of acute COVID-19, most of these cytokines, along with several markers of brain injuries, have recently emerged as potential biochemical indicators of long COVID-19 [46,57]. This evidence concerns the gene IL1B and COVID-19.